Determinants of non-participation in population-based breast cancer screening: a...
Lilu Ding - University of Groningen, Groningen, Netherlands
8 Oct 2020
Synchronous invasive ductal carcinoma of the breast and clear cell renal carcino...
Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon
8 Oct 2020
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
6 Oct 2020
Actionable pathogenic variant detection in breast cancer genes
Prof Gareth Evans - The Central Manchester NHS Foundation Trust, Manchester, UK
6 Oct 2020
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
6 Oct 2020
Prediction of hot flushes in women taking tamoxifen for breast cancer prevention
Michael Hale - Queen Mary University, London, UK
5 Oct 2020
The impact of COVID-19 on breast cancer screening, treatment, research and meeti...
Prof David Cameron - Representative EBC Council
5 Oct 2020
Improved decision making for older women with early breast cancer
Prof Lynda Wyld - University of Sheffield, Sheffield, UK
2 Oct 2020
MINDACT: 70-gene signature test as guidance for breast cancer treatment
Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlan...
1 Oct 2020
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negati...
Prof Fabrice André - Institut Gustave Roussy, Paris, France
29 Sep 2020
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
28 Sep 2020
Highlights from ESMO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
25 Sep 2020
